Octave® Bioscience, Inc. Announces Publication of Clinical Validation Study Results of its Novel, Multivariate Multiple Sclerosis Disease Activity (MSDA) Blood Test – Businesswire
Octave Bioscience proudly partnered with Olink Proteomics for an in-depth technical webinar featuring Ferhan Qureshi, VP of Biomarker Product Development at Octave, highlighting the importance of creating connections between organizations shaping MS research.
Managing Neurodegenerative Diseases with Better Data to Improve Outcomes
Bill Hagstrom, CEO, spoke to The Bio Report about the Octave's efforts to harness novel measurements of disease to individualize care, the case we're making with payers, and why we're starting with MS.
